CGChenglin Guo

Chenglin Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chenglin Guo has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pathological high-risk feature count and survival outcomes in patients with stage I invasive lung adenocarcinoma (≤3 cm): a retrospective cohort study

    by Jie Cao, Nan Chen, Yin Ku, Zhiyu Peng, Zhaokang Huang, Zetao Liu, Xizhou Liao, Xiaorong Zong, Peidi Li, Chenglin Guo, et al.

    Background: Pathological high-risk features in early-stage lung adenocarcinoma (LUAD) are associated with prognosis, but whether the number of coexisting features is associated with progressively worse prognosis remains uncertain. This study aimed to evaluate the prognostic impact of pathological high-risk feature count in patients with stage I invasive LUAD (≤3 cm). Methods: This retrospective cohort study included patients with stage I invasive LUAD (≤3 cm) who underwent complete resection between January 2018 and April 2025. Patients were stratified by the number of pathological high-risk features [lymphovascular invasion, visceral pleural invasion, spread through air spaces, high-grade histologic patterns (micropapillary, solid, and complex glandular patterns), and poor differentiation]. Relapse-free survival (RFS) and overall survival (OS) were estimated using the Kaplan-Meier method and compared using the log-rank test. Multivariable Cox regression analysis was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results: Among 4,030 patients, 2,791, 690, 296, and 253 had 0, 1, 2, and ≥3 pathological high-risk features, respectively. The median follow-up duration was 38 months for RFS and 39 months for OS. In the primary analysis, RFS was significantly worse for 1 versus 0 feature (log-rank PConclusions: A higher pathological high-risk feature count was associated with progressively worse prognosis in patients with stage I invasive LUAD (≤3 cm).

  • Open Access

    Lepidic pattern as a favorable prognostic factor in pathologically high-risk stage I invasive lung adenocarcinoma

    by Zhaokang Huang, Jie Cao, Nan Chen, Zhiyu Peng, Zetao Liu, Xizhou Liao, Xiaorong Zong, Peidi Li, Chenglin Guo, Lunxu Liu, et al.

    Background: The prognostic value of lepidic pattern in small stage I lung adenocarcinoma (LUAD) with pathological high-risk features remains unclear. This study evaluated whether lepidic pattern was associated with improved survival outcomes in this pathologically high-risk population. Methods: Consecutive patients with surgically resected stage I invasive LUAD measuring ≤3 cm at West China Hospital, Sichuan University, between January 2018 and April 2025 were retrospectively reviewed. Patients with at least one pathological high-risk feature were included and stratified according to the presence or absence of lepidic pattern. Recurrence-free survival (RFS) and overall survival (OS) were compared before and after propensity score matching. Cox regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results: A total of 1,233 patients were included, including 412 without lepidic pattern and 821 with lepidic pattern. After 1:1 propensity score matching, 315 matched pairs were generated. The median follow-up duration was 44 months. In the overall cohort, patients with lepidic pattern had better RFS than those without lepidic pattern, with 3-year RFS rates of 96.8% and 87.0%, respectively, and estimated 5-year RFS rates of 94.0% and 81.9%, respectively (HR, 0.42; 95% CI: 0.25–0.70; PConclusions: Lepidic pattern was independently associated with improved RFS, but not OS, in patients with pathologically high-risk small stage I LUAD. Lepidic pattern may serve as a complementary histologic marker for postoperative recurrence risk stratification.

  • Effect of adjuvant EGFR-TKI therapy on the prognosis of pathological stage I invasive lung adenocarcinoma with sensitive EGFR mutations

    by Zetao Liu, Zhiyu Peng, Jie Cao, Zhaokang Huang, Xizhou Liao, Xiaorong Zong, Chenglin Guo, Jiandong Mei


  • Open Access

    Arachidonic acid-mediated autophagy regulation drives crizotinib resistance in lung cancer: therapeutic opportunities and challenges

    by Hui Jie, Hongjin Lai, Zihuai Wang, Lunxu Liu, Senyi Deng, Chenglin Guo

    Arachidonic acid-mediated autophagy regulation drives crizotinib resistance in lung cancer: therapeutic opportunities and challenges

  • Open Access

    Targeting of arachidonic acid-modulated autophagy to enhance the sensitivity of ROS1+ or ALK+ non-small cell lung cancer to crizotinib therapy

    by Hui Jie, Hongjin Lai, Zihuai Wang, Min Yi, Yi Liu, Edyta Maria Urbanska, Eric Santoni-Rugiu, Shiyou Wei, Yuhao Chen, Chuan Li, et al.

    Background: As an approved targeting drug, crizotinib has been widely used in the treatment of patients with non-small cell lung cancer (NSCLC) with anaplastic lymphoma kinase (ALK) rearrangements or c-ros oncogene 1 (ROS1) fusions and has demonstrated remarkable therapeutic effects. However, crizotinib-treated patients frequently experience drug resistance, and there are still some underlying mechanisms, which remain unclear. Autophagy, a cellular process that involves the degradation and recycling of cellular components, has been implicated in the development of drug resistance. In this study, we aim to elucidate the mechanisms of crizotinib resistance involving autophagy dysregulation and identify novel therapeutic targets to overcome this resistance. Methods: We first established a model for crizotinib resistance in HCC78 and H3122 cells. Next, the level of proliferation, apoptosis, autophagy flux, and reactive oxygen species (ROS) of these cells were measured. Subsequently, we analyzed the published single-cell RNA sequencing data from three ALK-rearranged lung cancer organoid samples and performed a metabolomics assay on crizotinib-resistant HCC78 cells. Finally, the therapeutic effects were confirmed in vitro by targeting autophagy flux. Results: Crizotinib induced cell apoptosis and growth arrest by promoting the accumulation of autophagosomes through the inhibition of autophagy flux in ROS1+ or ALK+ NSCLC. In contrast, crizotinib-resistant NSCLC cells showed inactivation of signal transducer and activator of transcription 3 (STAT3) phosphorylation and downregulation of prostaglandin endoperoxide synthase 2 (PTGS2), leading to an increase in the metabolite arachidonic acid (AA). AA further promoted autophagy flux and reduced autophagosome accumulation, driving crizotinib resistance under conditions of drug stress. Moreover, chloroquine (CQ), anti-malaria drug and lysosome inhibitor developed in 1940, could induce cell death in crizotinib-resistant NSCLC by blocking AA-mediated autophagy flux and facilitating autophagosome accumulation, significantly enhancing the treatment efficacy of crizotinib in drug-resistant NSCLC. Conclusions: We discovered a new mechanism of first generation ALK- and ROS1-TKIs resistance, which points to the role of the metabolite AA in resistance to tyrosine kinase inhibitors. It may potentially provide an alternative strategy to overcoming crizotinib resistance in NSCLC treatment by reversing AA-mediated autophagy.


  • Open Access

    Surgical management of stage IE/IIE primary pulmonary lymphomas: a propensity score matching study

    by Jie Cao, Huahang Lin, Zhiyu Peng, Zhaokang Huang, Zetao Liu, Chenglin Guo, Jiandong Mei

    Background: Primary pulmonary lymphomas (PPLs) are rare malignancies that are frequently misdiagnosed due to their non-specific symptoms and ambiguous imaging findings. Although chemotherapy and radiation are typically the main treatment options, the role of surgery in managing PPLs remains uncertain. This study aimed to evaluate the impact of surgery on survival outcomes in patients with stage IE/IIE PPLs. Methods: We analyzed 2,693 patients with stage IE/IIE PPLs using Cox regression and Kaplan-Meier analyses to assess overall survival (OS) and cancer-specific survival (CSS). Subgroup analyses were performed based on histological subtypes, including mucosa-associated lymphoid tissue (MALT) lymphoma, diffuse large B-cell lymphoma (DLBCL), other non-Hodgkin’s lymphoma (NHL), and Hodgkin’s lymphoma (HL). Additionally, we analyzed tumor stage and patient characteristics. Propensity score matching (PSM) was applied to reduce potential biases. Results: Among the patients, 1,013 underwent surgery, while 1,680 did not. After PSM, surgery was associated with significantly improved OS [hazard ratio (HR) =0.75, 95% confidence interval (CI): 0.66–0.86, PConclusions: Surgery improves oncological outcomes for patients with stage IE/IIE DLBCL but does not provide survival benefits for MALT lymphoma, other NHL, or HL. Sublobectomy may be a viable surgical option when complete resection is achieved.


  • Open Access

    Prophylactic fiberoptic bronchoscopy after sleeve lobectomy can reduce the incidence of postoperative pneumonia: a propensity score matching study

    by Jie Cao, Zhiyu Peng, Huahang Lin, Zhaokang Huang, Zetao Liu, Qiang Pu, Lunxu Liu, Chenglin Guo, Jiandong Mei

    Background: Postoperative pneumonia (POP) predicts poor outcomes after lung surgery, especially for patients undergoing sleeve lobectomy. Fiberoptic bronchoscopy (FOB) is frequently used in the treatment of POP for patients receiving sleeve lobectomy. This study aimed to assess the effect of prophylactic FOB on the incidence of POP in these patients. Methods: This is a single-center retrospective cohort study. Postoperative outcomes of patients who underwent sleeve lobectomy for central lung cancer from August 2005 to August 2020 in the West China Hospital were collected. The included patients were divided into two groups based on whether prophylactic FOB was performed, and the two groups were compared using propensity score matching (PSM). Results: A total of 314 patients were included in this study. There were 166 patients in the aspirated group and 148 patients in the non-aspirated group. PSM resulted in 133 patients in each group. The aspirated group was associated with a lower incidence of POP (7.5% vs. 17.3%; P=0.03), shorter duration of antibiotic use (5.6±3.3 vs. 6.9±3.9 days; P=0.003), and shorter postoperative hospital stay (9.3±4.8 vs. 10.7±5.5 days; P=0.04). Conclusions: Prophylactic FOB after sleeve lobectomy was associated with improved postoperative outcomes and might be recommended for patients undergoing sleeve lobectomy.


  • Open Access

    Analyzing dissemination, quality, and reliability of Chinese brain tumor-related short videos on TikTok and Bilibili: a cross-sectional study

    by Ren Zhang, Zhiwei Zhang, Hui Jie, Yi Guo, Yi Liu, Yuan Yang, Chuan Li, Chenglin Guo

    Background: As the Internet becomes an increasingly vital source of medical information, the quality and reliability of brain tumor-related short videos on platforms such as TikTok and Bilibili have not been adequately evaluated. Therefore, this study aims to assess these aspects and explore the factors influencing the dissemination of such videos.Methods: A cross-sectional analysis was conducted on the top 100 brain tumor-related short videos from TikTok and Bilibili. The videos were evaluated using the Global Quality Score and the DISCERN reliability instrument. An eXtreme Gradient Boosting algorithm was utilized to predict dissemination outcomes. The videos were also categorized by content type and uploader.Results: TikTok videos scored relatively higher on both the Global Quality Score (median 2, interquartile range [2, 3] on TikTok vs. median 2, interquartile range [1, 2] on Bilibili, p = 1.51E-04) and the DISCERN reliability instrument (median 15, interquartile range [13, 18.25] on TikTok vs. 13.5, interquartile range [11, 16] on Bilibili, p = 1.66E-04). Subgroup analysis revealed that videos uploaded by professional individuals and institutions had higher quality and reliability compared to those uploaded by non-professional entities. Videos focusing on disease knowledge exhibited the highest quality and reliability compared to other content types. The number of followers emerged as the most important variable in our dissemination prediction model.Conclusion: The overall quality and reliability of brain tumor-related short videos on TikTok and Bilibili were unsatisfactory and did not significantly influence video dissemination. Future research should expand the scope to better understand the factors driving the dissemination of medical-themed videos.


  • Open Access

    The prognostic value of visceral pleural infiltration in ≤3 cm nonsmall cell lung cancer presenting with ground glass opacity: an inverse probability of treatment weighting study

    by Zhenyu Yang, Yiming Li, Chenglin Guo, Yikai Xing, Chengwu Liu, Jian Zhang, Qiang Pu, Lunxu Liu

    Background: Visceral pleural infiltration (VPI) has been identified as an important risk factor in nonsmall cell lung cancer (NSCLC) for many decades. However, for patients who present with ground glass opacity (GGO), the prognostic value of VPI is still elusive. The authors aimed to investigate whether the VPI is a significant prognostic factor in surgically resected ≤3 cm stage I NSCLC, who presented with GGO. Materials and methods: Patients with primary NSCLC who underwent surgical resection between December 2009 and December 2018 were collected. Stage I tumors that presented as GGO nodules with a tumor size of less than 3 cm were included and divided into two groups based on VPI status (positive and negative). Clinical, pathological, and prognostic data were prospectively collected and retrospectively reviewed. Inverse probability of treatment weighting (IPTW) was used to balance baseline characteristics. Overall survival (OS) and recurrence-free survival (RFS) were analyzed using the Cox proportional hazards model and Kaplan–Meier method. Results: A total of 2043 patients were included in this study (VPIs were found in 196 patients). After IPTW weighting, all factors between the two groups were balanced. The median follow-up time was 67.3 months. According to the multivariable Cox models, the VPI was not a significant prognostic factor for OS (HR=2.00, 95% CI: 0.96–4.17; P=0.063), but was significant for RFS (HR=2.00, 95% CI: 1.12–3.55; P=0.019). In subgroup analysis, we found VPI was significant for OS (HR=3.17, 95% CI: 1.09–9.26, P=0.035) and RFS (HR=4.07, 95% CI: 1.76–9.40, P=0.001) in patients with a tumor size >1 cm and a consolidation to tumor ratio (CTR) >50%. For patients with a tumor size ≤1 cm or a CTR ≤50%, the VPI was not significant. Conclusions: VPI may be a significant risk factor for GGOs in NSCLC patients with a tumor size >1 cm and a CTR >50%. Further prospective studies conducted across multicenters with a larger sample size are needed.


  • Open Access

    Intentional wedge resection versus segmentectomy for ≤2 cm ground-glass-opacity-dominant non-small cell lung cancer: a real-world study using inverse probability of treatment weighting

    by Chengwu Liu, Zhenyu Yang, Yiming Li, Chenglin Guo, Liang Xia, Weiheng Zhang, Congjia Xiao, Jiandong Mei, Hu Liao, Yunke Zhu, et al.

    Background: Whether wedge resection is oncological suitable for ground glass opacity (GGO)-dominant non-small cell lung cancer (NSCLC) ≤2 cm is still debatable. The aim of this study is to investigate the short-term and long-term outcomes of intentional wedge resection and segmentectomy for those patients. Materials and Methods: This was a real-world study from one of the largest thoracic surgery centers in West China. Patients who underwent intentional wedge resection or segmentectomy for ≤2 cm CTR (consolidation-to-tumor) ≤0.5 NSCLC were consecutively included between December 2009 and December 2018. Data were prospectively collected and retrospectively reviewed. Inverse probability of treatment weighting (IPTW) was used to balance baseline characteristics. Long-term outcomes, including overall survival (OS), recurrence-free survival (RFS), and lung cancer-specific survival (LCSS), were analyzed using Cox proportional model. Results: A total of 1209 patients were included (497 in the wedge resection group, 712 in the segmentectomy group). Compared to segmentectomy, wedge resection had a significantly lower rate of complications (3.8 vs. 7.7%, P=0.008), a shorter operating time (65 min vs. 114 min, PPP=0.270), 5-year RFS (98.8 vs. 99.5%, HR=1.88, 95% CI: 0.56–6.31, P=0.307) and 5-year LCSS (99.9 vs. 99.6%, HR=1.76, 95% CI: 0.24–13.15, P=0.581). Conclusion: Intentional wedge resection is an appropriate choice for ≤2 cm GGO-dominant NSCLC.